Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption

J Biol Chem. 2007 Aug 31;282(35):25509-16. doi: 10.1074/jbc.M610782200. Epub 2007 May 11.

Abstract

Multiple signaling pathways participate in the regulation of bone remodeling, and pathological negative balance in the regulation results in osteoporosis. However, interactions of signaling pathways that act comprehensively in concert to maintain bone mass are not fully understood. We investigated roles of parathyroid hormone receptor (PTH/PTHrP receptor) signaling in osteoblasts in unloading-induced bone loss using transgenic mice. Hind limb unloading by tail suspension reduced bone mass in wild-type mice. In contrast, signaling by constitutively active PTH/PTHrP receptor (caPPR), whose expression was regulated by the osteoblast-specific Col1a1 promoter (Col1a1-caPPR), suppressed unloading-induced reduction in bone mass in these transgenic mice. In Col1a1-caPPR transgenic (Tg) mice, hind limb unloading suppressed bone formation parameters in vivo and mineralized nodule formation in vitro similarly to those observed in wild-type mice. In addition, serum osteocalcin levels and mRNA expression levels of type I collagen, Runx2 and Osterix in bone were suppressed by unloading in both wild-type mice and Tg mice. However, in contrast to unloading-induced enhancement of bone resorption parameters in wild-type mice, Col1a1-caPPR signaling suppressed, rather than enhanced, osteoclast number and osteoclast surface as well as urinary deoxypyridinoline excretion upon unloading. Col1a1-caPPR signaling also suppressed mRNA expression levels of RANK and c-fms in bone upon unloading. Although the M-CSF and monocyte chemoattractant protein 1 (MCP-1) mRNA levels were enhanced in control Tg mice, these levels were suppressed in unloaded Tg mice. These results indicated that constitutive activation of PTH/PTHrP receptor signaling in osteoblastic cells suppresses unloading-induced bone loss specifically through the regulation of osteoclastic activity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Resorption / genetics
  • Bone Resorption / metabolism*
  • Bone Resorption / pathology
  • Chemokine CCL2 / biosynthesis
  • Chemokine CCL2 / genetics
  • Collagen Type I / biosynthesis
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Collagen Type I, alpha 1 Chain
  • Core Binding Factor Alpha 1 Subunit / biosynthesis
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Female
  • Gene Expression Regulation* / genetics
  • Hindlimb Suspension
  • Humans
  • Macrophage Colony-Stimulating Factor / biosynthesis
  • Macrophage Colony-Stimulating Factor / genetics
  • Male
  • Mice
  • Mice, Transgenic
  • Osteoblasts / metabolism*
  • Osteoblasts / pathology
  • Osteocalcin / genetics
  • Osteocalcin / metabolism
  • Osteoclasts / metabolism
  • Osteoclasts / pathology
  • Osteogenesis / genetics
  • Osteoporosis / genetics
  • Osteoporosis / metabolism
  • Osteoporosis / pathology
  • Parathyroid Hormone / genetics
  • Parathyroid Hormone / metabolism
  • Promoter Regions, Genetic / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptors, Parathyroid Hormone / biosynthesis*
  • Receptors, Parathyroid Hormone / genetics
  • Signal Transduction* / genetics
  • Sp7 Transcription Factor
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics

Substances

  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Core Binding Factor Alpha 1 Subunit
  • Parathyroid Hormone
  • RNA, Messenger
  • Receptors, Parathyroid Hormone
  • Runx2 protein, mouse
  • Sp7 Transcription Factor
  • Sp7 protein, mouse
  • Transcription Factors
  • Osteocalcin
  • Macrophage Colony-Stimulating Factor